Xin Fang Li
Directeur Général chez MabPlex International Co., Ltd.
Postes actifs de Xin Fang Li
Sociétés | Poste | Début | Fin |
---|---|---|---|
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Directeur/Membre du Conseil | 01/01/2022 | - |
Directeur Général | 01/01/2022 | - |
Historique de carrière de Xin Fang Li
Formation de Xin Fang Li
Peking University | Doctorate Degree |
Statistiques
Internationale
Chine | 3 |
Opérationnelle
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Health Technology |
- Bourse
- Insiders
- Xin Fang Li
- Expérience